Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century

被引:9
作者
Aday, Jacob S. [1 ]
Bloesch, Emily K. [1 ]
Davoli, Christopher C. [1 ]
机构
[1] Cent Michigan Univ, Dept Psychol, 101 Sloan Hall, Mt Pleasant, MI 48859 USA
关键词
Historiography; history of psychology; LSD; mescaline; psychedelic drugs; psychedelic zeitgeist; PSILOCYBIN; ANXIETY; EXPERIENCE; PSYCHOTHERAPY; MESCALINE; ATTITUDES;
D O I
10.1080/02791072.2019.1581961
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
During the 1950s and 1960s, there was a tremendous surge in research into the effects of psychedelic drugs. When discussing this period of research, the discovery of the psychoactive properties of LSD in 1943 is often presented as the main, and sometimes only, driving force of the boom in research. This "Great Person," or "Great Chemical," historiographical lens fails to acknowledge other factors that were fundamental in setting the stage for the research. In particular, other psychedelic drugs, such as mescaline, were already being probed for their uses in psychotherapy and as models for psychosis before the effects of LSD had been discovered. Psilocybin and other classical psychedelics had also been discovered by Western researchers around the same time as the synthesis of LSD. Additionally, many of the dominant zeitgeists (e.g., pharmacological, psychoanalytic, and humanistic) in psychology during this period were congruent with psychedelic research. This article argues that while the discovery of LSD may have been a catalyst for psychedelic research in the 1950s and '60s, there was a broader psychedelic zeitgeist that deserves acknowledgement for setting the stage.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 63 条
[11]   The increasing burden of mental and neurological disorders [J].
Catala-Lopez, Ferran ;
Genova-Maleras, Ricard ;
Vieta, Eduard ;
Tabares-Seisdedos, Rafael .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (11) :1337-1339
[12]  
Dakwar E., 2016, DRUG ALCOHOL DEPEN, V165, P293, DOI [10.1016/j.drugalcdep.2016.04.003, DOI 10.1016/j.drugalcdep.2016.04.003, DOI 10.1016/J.DRUGALCDEP.2016.04.003]
[13]   Flashback: Psychiatric experimentation with LSD in historical perspective [J].
Dyck, E .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (07) :381-388
[14]  
Fadiman J., 2003, J TRANSPERSONAL PSY, V35, P111
[15]   Observations on taking Peyote (Anhalonium Lewinii) [J].
Fernberger, SW .
AMERICAN JOURNAL OF PSYCHOLOGY, 1923, 34 :267-270
[16]   Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness [J].
Forstmann, Matthias ;
Sagioglou, Christina .
JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (08) :975-988
[17]   LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects [J].
Gasser, Peter ;
Kirchner, Katharina ;
Passie, Torsten .
JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (01) :57-68
[18]   History, rationale and potential of human experimental hallucinogenic drug research in psychiatry [J].
Gouzoulis-Mayfrank, E ;
Hermle, L ;
Thelen, B ;
Sass, H .
PHARMACOPSYCHIATRY, 1998, 31 :63-68
[19]   Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance [J].
Griffiths, R. R. ;
Richards, W. A. ;
McCann, U. ;
Jesse, R. .
PSYCHOPHARMACOLOGY, 2006, 187 (03) :268-283
[20]   Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors [J].
Griffiths, Roland R. ;
Johnson, Matthew W. ;
Richards, William A. ;
Richards, Brian D. ;
Jesse, Robert ;
MacLean, Katherine A. ;
Barrett, Frederick S. ;
Cosimano, Mary P. ;
Klinedinst, Maggie A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (01) :49-69